| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
11,732 |
2,392 |
$1.06M |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
2,587 |
2,247 |
$201K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
1,617 |
1,539 |
$97K |
| 97161 |
|
762 |
639 |
$78K |
| 97162 |
|
480 |
428 |
$53K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
1,204 |
1,150 |
$43K |
| 80053 |
Comprehensive metabolic panel |
5,262 |
3,840 |
$23K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
1,557 |
277 |
$18K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
92 |
53 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
6,562 |
4,850 |
$10K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
322 |
290 |
$10K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
654 |
229 |
$8K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,513 |
1,258 |
$7K |
| 72110 |
|
396 |
385 |
$7K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
642 |
597 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
753 |
698 |
$6K |
| 97010 |
|
230 |
51 |
$4K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
688 |
678 |
$3K |
| 77066 |
Tomosynthesis, mammo |
42 |
38 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
897 |
792 |
$3K |
| 82607 |
|
727 |
645 |
$2K |
| 72050 |
|
154 |
153 |
$2K |
| 72100 |
|
166 |
159 |
$2K |
| 82728 |
|
977 |
851 |
$1K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
379 |
345 |
$1K |
| 83550 |
|
598 |
539 |
$1K |
| 85610 |
|
924 |
696 |
$1K |
| 83735 |
|
553 |
436 |
$1K |
| 82746 |
|
411 |
364 |
$984.77 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
45 |
38 |
$982.37 |
| 80061 |
Lipid panel |
777 |
741 |
$941.66 |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
99 |
56 |
$936.40 |
| 88108 |
|
241 |
231 |
$923.85 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
619 |
586 |
$916.08 |
| 84439 |
|
554 |
418 |
$883.78 |
| 92558 |
|
75 |
71 |
$852.09 |
| 83540 |
|
623 |
563 |
$838.62 |
| 86038 |
|
111 |
94 |
$830.01 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
72 |
66 |
$792.36 |
| 83615 |
|
318 |
265 |
$749.70 |
| 81003 |
|
1,257 |
1,125 |
$732.90 |
| G0283 |
Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
55 |
12 |
$731.53 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
13 |
12 |
$667.03 |
| 72040 |
|
57 |
55 |
$588.16 |
| 86901 |
|
594 |
538 |
$585.44 |
| 86850 |
|
529 |
486 |
$579.50 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
254 |
239 |
$578.80 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
16 |
16 |
$524.40 |
| 87581 |
|
92 |
53 |
$512.46 |
| 87486 |
|
92 |
53 |
$512.46 |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
98 |
92 |
$494.28 |
| 86900 |
|
551 |
504 |
$357.67 |
| 85045 |
|
373 |
304 |
$309.87 |
| 84165 |
|
44 |
43 |
$255.50 |
| 85730 |
|
202 |
176 |
$246.01 |
| 97166 |
|
24 |
12 |
$166.93 |
| 85651 |
|
189 |
167 |
$159.16 |
| 36415 |
Collection of venous blood by venipuncture |
853 |
740 |
$143.96 |
| 73562 |
|
16 |
13 |
$137.62 |
| 83516 |
|
49 |
25 |
$98.21 |
| 87186 |
|
16 |
12 |
$82.50 |
| 86140 |
|
95 |
80 |
$70.99 |
| 84160 |
|
43 |
42 |
$58.65 |
| 81025 |
|
53 |
39 |
$51.53 |
| 86592 |
|
73 |
53 |
$46.84 |
| 84100 |
|
30 |
25 |
$45.32 |
| 84702 |
|
14 |
12 |
$43.12 |
| 87340 |
|
17 |
13 |
$39.60 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
740 |
324 |
$19.42 |
| 84425 |
|
15 |
15 |
$18.72 |
| 82247 |
|
15 |
15 |
$18.14 |
| 82043 |
|
15 |
13 |
$17.33 |
| 84075 |
|
12 |
12 |
$12.20 |
| 84450 |
|
12 |
12 |
$12.20 |
| 84155 |
|
12 |
12 |
$8.75 |
| 36591 |
|
414 |
151 |
$0.00 |
| G8982 |
Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
15 |
12 |
$0.00 |
| G8984 |
Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals |
146 |
96 |
$0.00 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
290 |
237 |
$0.00 |
| G8985 |
Carrying, moving and handling objects, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
198 |
137 |
$0.00 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
345 |
265 |
$0.00 |